Transcriptomic profiling of GBM cells treated with the USP8 inhibitor DUB-IN-1 revealed altered expression of multiple genes implicated in tumorigenesis, including the key cell cycle regulator Aurora kinase A (AURKA). This evidence concerns the gene AURKA and glioblastoma.